Rxo (RXO) Shares Outstanding (Weighted Average) (2021 - 2026)

Rxo (RXO) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $169.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 0.64% year-over-year to $169.1 million; the trailing twelve-month figure through Mar 2026 stood at $169.1 million (up 0.64% YoY), and the FY2025 full-year result was $168.5 million, up 26.27% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $169.1 million, roughly flat from $168.5 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $169.1 million in Q1 2026 and bottomed at $115.2 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $117.2 million (2024), against an average of $133.0 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) gained 0.14%; it then jumped 43.55% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $115.3 million in 2022, then increased by 1.33% to $116.9 million in 2023, then grew by 14.15% to $133.4 million in 2024, then rose by 26.27% to $168.5 million in 2025, then climbed by 0.38% to $169.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $169.1 million (Q1 2026), $168.5 million (Q4 2025), and $168.4 million (Q3 2025), per Business Quant data.

Peer Comparison